PLASMA PROPRANOLOL BEFORE, DURING, AND AFTER CARDIOPULMONARY BYPASS

被引：26

作者：

PLACHETKA, JR

SALOMON, NW

COPELAND, JG

机构：

[1] UNIV ARIZONA,COLL MED,HLTH SCI CTR,DIV CARDIOVASC & THORAC SURG,TUCSON,AZ 85724

[2] UNIV ARIZONA,COLL PHARM,DEPT PHARM PRACTICE,TUCSON,AZ 85724

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1981年 / 30卷 / 06期

关键词：

D O I：

10.1038/clpt.1981.233

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：745 / 751

页数：7

相关论文

共 29 条

[1] ABEL BF, 1980, ANN THORAC SURG, V29, P109
[2] BETA-ADRENERGIC-RECEPTOR LIGAND-BINDING BY RABBIT LUNG
BLANCK, TJJ
GILLIS, CN
[J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (12) : 1903 - 1909
[3] THE CLINICAL IMPORTANCE OF CARDIOSELECTIVITY AND LIPOPHILICITY IN BETA-BLOCKERS
CRUICKSHANK, JM
[J]. AMERICAN HEART JOURNAL, 1980, 100 (02) : 160 - 178
[4] CONCENTRATION OF (+ OR -)-PROPRANOLOL IN ISOLATED, PERFUSED LUNGS OF RAT
DOLLERY, CT
JUNOD, AF
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1976, 57 (01) : 67 - 71
[5] 1ST PASS UPTAKE OF PROPRANOLOL-C-14 BY THE LUNG
GEDDES, DM
NESBITT, K
TRAILL, T
BLACKBURN, JP
[J]. THORAX, 1979, 34 (06) : 810 - 813
[6] HAYES A, 1971, J PHARMACOL EXP THER, V176, P302
[7] JOHNSSON G, 1976, Clinical Pharmacokinetics, V1, P233
[8] PROPRANOLOL THERAPY IN PATIENTS UNDERGOING MYOCARDIAL REVASCULARIZATION
JONES, EL
KAPLAN, JA
DORNEY, ER
KING, SB
DOUGLAS, JS
HATCHER, CR
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1976, 38 (06) : 696 - 700
[9] UPTAKE OF PROPRANOLOL BY THE LUNG AND ITS DISPLACEMENT BY OTHER DRUGS - INVOLVEMENT OF THE ALVEOLAR MACROPHAGE
KORNHAUSER, DM
VESTAL, RE
SHAND, DG
[J]. PHARMACOLOGY, 1980, 20 (05) : 275 - 283
[10] KOSKA AJ, 1981, CLIN PHARM THER, V19, P100